Healthcare, Life Sciences and Pharma risk and risk management

Healthcare Life Sciences Pharma

Is risk getting enough attention in the NHS?

The potential for ”unintended consequences” is high as healthcare systems become more complex - BMJ

Digital health sector overexposed - survey

More than two thirds lack insurance coverage for bodily injury claims arising from system failure or cyber breach

Healthcare leads data risk assessments – Trustwave study

UK professionals value their personally identifiable data at less than half as much as their US counterparts, according to a report from tech firm Trustwave

Germany exempted from mandatory rebates for pharmaceutical companies

The European Commission found that the scheme pursues an objective of common interest

Healthcare in Africa improves amid Ebola outbreak

International SOS’ analysis reveals the world’s most dangerous locations concerning health risk

Ebola: EU announces medium/long-term support through development co-operation

Efforts should ultimately help contain, control, treat and defeat the disease

Does your insurance cover you for Ebola-related claims?

With the disease spreading further and further, corporate policyholders would be wise to assess their insurance coverage

EU to boost Ebola research with €24.4m

Funding to go to five projects via a fast-track procedure

Q&A: Ebola and the health implications for the EU

With the number of cases now having reached more than 8,000, the EU has issued a Q&A on the deadly virus